Biotech & Medtech
Biotech & Medtech news — Saturday 07 November 2026
4 stories from 1 source, every one in English. Each links to its publisher.
-
Lowering blood pressure after stroke or with diabetes poses challenges, in research and practice
STAT News
CHICAGO — High blood pressure has earned its reputation as the silent killer. If someone has diabetes or has had a stroke, the risk of serious cardiovascular events posed by hypertension climbs even higher. Three studies presented Saturday…
-
STAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries
STAT News
WASHINGTON — The Biotechnology Innovation Organization is joining the legal fight against the Trump administration’s pilot program aimed at aligning drug prices in Medicare with prices charged in peer countries. BIO and two…
-
STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy
STAT News
CHICAGO — Lipoprotein(a), a genetic risk factor for cardiovascular disease carried by 1 in 5 people, is the target of novel therapies trying to cut down heart attacks, strokes, and deaths in those at risk. The growing field of research…
-
STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories
STAT News
CHICAGO — Out-of-control inflammation is often called the root of all evil in cardiovascular and metabolic disease. Recent clinical trial results, described in brief in July , showed that while an experimental drug could lower two…